Published in Gut on July 22, 2013
Poor Correlation Between Clinical Disease Activity and Mucosal Inflammation, and the Role of Psychological Comorbidity, in Inflammatory Bowel Disease. Am J Gastroenterol (2016) 1.43
Irritable bowel syndrome: emerging paradigm in pathophysiology. World J Gastroenterol (2014) 1.03
Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiol (2015) 0.98
Elevated circulating miR-150 and miR-342-3p in patients with irritable bowel syndrome. Exp Mol Pathol (2014) 0.90
Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Mediators Inflamm (2015) 0.87
Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions. World J Gastroenterol (2014) 0.87
Colitis-induced neuroplasticity disrupts motility in the inflamed and post-inflamed colon. J Clin Invest (2015) 0.86
IBS-like symptoms in patients with ulcerative colitis. Clin Exp Gastroenterol (2015) 0.86
Gastrointestinal mucosal barrier function and diseases. J Gastroenterol (2016) 0.85
A gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, ameliorates intestinal epithelial barrier impairment partially via GPR40-MEK-ERK pathway. J Biol Chem (2014) 0.85
Gastrointestinal motility disorders in inflammatory bowel diseases. World J Gastroenterol (2014) 0.84
Flavonoids in Inflammatory Bowel Disease: A Review. Nutrients (2016) 0.82
Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place. Intest Res (2016) 0.82
Interleukin 34: a new modulator of human and experimental inflammatory bowel disease. Clin Sci (Lond) (2015) 0.81
Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? Therap Adv Gastroenterol (2016) 0.81
Prevalence of Irritable Bowel Syndrome-like Symptoms in Japanese Patients with Inactive Inflammatory Bowel Disease. J Neurogastroenterol Motil (2016) 0.80
Condition-specific role of colonic inflammatory molecules in persistent functional colorectal hypersensitivity in the mouse. Neurogastroenterol Motil (2014) 0.80
Crosstalk between Inflammation and ROCK/MLCK Signaling Pathways in Gastrointestinal Disorders with Intestinal Hyperpermeability. Gastroenterol Res Pract (2016) 0.79
Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis. Immunology (2015) 0.79
IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol (2016) 0.79
The analysis of factors associated with progression of isolated terminal ileal lesions. PLoS One (2014) 0.79
Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation. Hum Vaccin Immunother (2014) 0.78
Endoscopy-Guided Evaluation of Duodenal Mucosal Permeability in Functional Dyspepsia. Clin Transl Gastroenterol (2017) 0.77
Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel Disease. Mediators Inflamm (2016) 0.77
Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases. Nutr J (2016) 0.77
Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Res (2016) 0.77
Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease. Int J Mol Sci (2016) 0.76
New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists. Therap Adv Gastroenterol (2016) 0.76
Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol (2017) 0.76
Claudin-2 expression is upregulated in the ileum of diarrhea predominant irritable bowel syndrome patients. J Clin Biochem Nutr (2017) 0.75
Host-microbiome interaction in Crohn's disease: A familiar or familial issue? World J Gastrointest Pathophysiol (2015) 0.75
Functional bowel symptoms in quiescent inflammatory bowel disease: more than just irritable bowel syndrome? Gastroenterology (2014) 0.75
The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial. Sci Rep (2017) 0.75
The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties. Sci Rep (2016) 0.75
Basal Plasma Levels of Copeptin are Elevated in Inactive Inflammatory Bowel Disease after Bowel Resection. Drug Target Insights (2015) 0.75
Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World J Gastrointest Pharmacol Ther (2016) 0.75
Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study. United European Gastroenterol J (2016) 0.75
Close association between intestinal microbiota and irritable bowel syndrome. Eur J Clin Microbiol Infect Dis (2017) 0.75
Beyond the flavor: A green formulation of Ferula asafoetida oleo-gum-resin with fenugreek dietary fibre and its gut health potential. Toxicol Rep (2017) 0.75
Berberine alleviates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress. Exp Ther Med (2017) 0.75
Control of lupus nephritis by changes of gut microbiota. Microbiome (2017) 0.75
Early intervention with Bifidobacterium lactis NCC2818 modulates the host-microbe interface independent of the sustained changes induced by the neonatal environment. Sci Rep (2017) 0.75
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut (2008) 3.52
ESPEN guidelines on artificial enteral nutrition--percutaneous endoscopic gastrostomy (PEG). Clin Nutr (2005) 3.39
Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther (2012) 2.51
Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience. Aliment Pharmacol Ther (2013) 2.30
Plasma carnitine is associated with fatigue in chronic hepatitis C but not in the irritable bowel syndrome. Aliment Pharmacol Ther (2011) 2.08
Chronic pancreatitis and inflammatory bowel disease: true or coincidental association? Am J Gastroenterol (1999) 1.90
ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. Eur J Immunol (1998) 1.88
Review article: yeast as probiotics -- Saccharomyces boulardii. Aliment Pharmacol Ther (2007) 1.83
EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy (2014) 1.80
The putative role of inflammation in the irritable bowel syndrome. Gut (2001) 1.51
How to use articles about harm: the relationship between high tidal volumes, ventilating pressures, and ventilator-induced lung injury. Crit Care Med (1997) 1.44
Infliximab for refractory ulcerative proctitis. Aliment Pharmacol Ther (2010) 1.42
Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis. Aliment Pharmacol Ther (2013) 1.41
A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J (1999) 1.41
Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy. Arch Toxicol (1986) 1.34
Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur J Immunol (1997) 1.27
Endoscopic argon plasma trimming of biliary and gastrointestinal metallic stents. Endoscopy (2005) 1.26
Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. Blood (2000) 1.25
Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur J Immunol (1997) 1.24
Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut (2008) 1.24
Fatigue is associated with high circulating leptin levels in chronic hepatitis C. Gut (2002) 1.21
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies. Aliment Pharmacol Ther (2010) 1.18
Chronic pulmonary paracoccidioidomycosis (South American blastomycosis): high-resolution CT findings in 41 patients. AJR Am J Roentgenol (1999) 1.17
Breast milk immune complexes are potent inducers of oral tolerance in neonates and prevent asthma development. Mucosal Immunol (2010) 1.14
Trypanosoma cruzi infects human dendritic cells and prevents their maturation: inhibition of cytokines, HLA-DR, and costimulatory molecules. Infect Immun (1999) 1.12
Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease. Eur J Gastroenterol Hepatol (2000) 1.10
CD99 engagement: an effective therapeutic strategy for Ewing tumors. Cancer Res (2000) 1.08
Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells. Am J Gastroenterol (2011) 1.07
Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells. J Immunol (1997) 1.05
CD99 signals caspase-independent T cell death. J Immunol (2001) 1.01
CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity. Oncogene (2007) 0.96
Mesalazine 4 g daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis. Inflamm Bowel Dis (2001) 0.96
Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma. Clin Exp Immunol (1994) 0.95
[Adaptation of the complement fixation microtechnic to the diagnosis of equine plague]. Rev Elev Med Vet Pays Trop (1975) 0.95
Hepatitis C virus and Hashimoto's thyroiditis. Eur J Med (1992) 0.95
Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome. Neurogastroenterol Motil (2010) 0.94
Energy metabolism and substrate oxidation in patients with Crohn's disease. Nutrition (2000) 0.93
Luminal CCK-releasing factors in the isolated vascularly perfused rat duodenojejunum. Am J Physiol (1990) 0.93
Postnatal fish oil supplementation in high-risk infants to prevent allergy: randomized controlled trial. Pediatrics (2012) 0.93
Caspase-independent commitment phase to apoptosis in activated blood T lymphocytes: reversibility at low apoptotic insult. Blood (2000) 0.92
Tolerance and efficacy of argon plasma coagulation for controlling bleeding in patients with typical and atypical manifestations of watermelon stomach. Endoscopy (2003) 0.92
A systematic review and meta-analysis of the impact of oral nutritional supplements on hospital readmissions. Ageing Res Rev (2013) 0.92
Non invasive prediction of severe fibrosis in patients with alcoholic liver disease. Gastroenterol Clin Biol (2000) 0.90
Predictive factors of bleeding related to post-banding ulcer following endoscopic variceal ligation in cirrhotic patients: a case-control study. Aliment Pharmacol Ther (2010) 0.90
Hepatitis B screening in a New York City obstetrics service. Am J Public Health (1988) 0.90
Resting energy expenditure in chronic hepatitis C. J Hepatol (2000) 0.90
[Imaging of inflammatory pseudotumors of the liver]. J Radiol (2007) 0.89
The relationship between maternal folate status in pregnancy, cord blood folate levels, and allergic outcomes in early childhood. Allergy (2011) 0.89
Inhibition of human dendritic cell functions by methylprednisolone. Transplantation (1999) 0.89
Effects of oral creatine supplementation on maximal pedalling performance in older adults. Eur J Appl Physiol (2001) 0.89
The histological spectrum of visceral leishmaniasis caused by Leishmania infantum MON-1 in acquired immune deficiency syndrome. Hum Pathol (2000) 0.88
Autopsy findings in the acquired immunodeficiency syndrome (AIDS). A report of 395 cases from the south of France. Pathol Res Pract (1999) 0.88
Regressive or lethal lead encephalopathy in the suckling rat. Correlation of lead levels and morphological findings. J Neuropathol Exp Neurol (1983) 0.88
Tools used to measure airway remodelling in research. Eur Respir J (2007) 0.88
Total artificial nutrition is associated with major changes in the fecal flora. Eur J Nutr (2000) 0.88
[Wirsungorrhagia complicating chronic pancreatitis associated with a neuroendocrine tumor of the pancreas]. Gastroenterol Clin Biol (1994) 0.88
Genes, isochores and bands in human chromosomes 21 and 22. Chromosome Res (2001) 0.87
Traumatic neuroma of the cystic duct with biliary obstruction. Report of a case. Acta Gastroenterol Belg (2003) 0.87
[Treatment of vaginal moniliasis during pregnancy with a new biologic antifungal agent: pimaricin]. Can Med Assoc J (1966) 0.87
Peanut allergens are rapidly transferred in human breast milk and can prevent sensitization in mice. Allergy (2014) 0.87
Frequency and severity of ileal adenomas in familial adenomatous polyposis after colectomy. Endoscopy (2007) 0.86
Fish oil supplementation in early infancy modulates developing infant immune responses. Clin Exp Allergy (2012) 0.86
Phenotyping of intrahepatic and peripheral blood lymphocytes in patients with chronic hepatitis C. Dig Dis Sci (1997) 0.86
Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients. Aliment Pharmacol Ther (2008) 0.85
[Splenic artery aneurysm: diagnosis and endovascular therapy]. J Radiol (2010) 0.85
Bone metastasis from endometrioid ovarian carcinoma: a case study and literature review. Eur J Gynaecol Oncol (2009) 0.84
Diversity of ARSACS mutations in French-Canadians. Can J Neurol Sci (2013) 0.84
[Disseminated infection due to Scedosporium apiospermum in liver transplantation. Differential diagnosis from invasive aspergillosis]. Ann Pathol (1993) 0.83
Lead distribution in the nervous system of 8-month-old rats intoxicated since birth by lead. Experientia (1983) 0.83
Effect of dexamethasone on transport of alpha-aminoisobutyric acid and sucrose across the blood-brain barrier. J Neurochem (1988) 0.83
Vascular smooth muscle differentiation of murine stroma: a sequential model. Exp Hematol (1999) 0.83
An economic analysis of the illicit drug market. Int J Addict (1983) 0.82
Acarbose and lymphocytic colitis. Lancet (2000) 0.82
[Bacillary angiomatosis and cutaneous cytomegalovirus infections in AIDS: a fortuitous association?]. Ann Pathol (1993) 0.82
[Comparative study of the efficacy and acceptability of amineptine and fluoxetine in patients with major depression]. Encephale (1993) 0.82
Spontaneous esophageal hematoma: diagnostic contribution of echoendoscopy. Gastrointest Endosc (1994) 0.82
Peripheral neuropathy in styrene-exposed workers. Scand J Work Environ Health (1995) 0.82
Mother to child transfer of IgG and IgA antibodies against Dermatophagoides pteronyssinus. Scand J Immunol (2011) 0.82
Evidence of melanin-concentrating hormone-containing neurons supplying both cortical and neuroendocrine projections. Neuroscience (2003) 0.82
Low risk of irritable bowel syndrome after Clostridium difficile infection. Can J Gastroenterol (2007) 0.82